Globus Medical (GMED) Reports Preliminary Sales Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Globus Medical (GMED) PT Raised to $101 at Canaccord Genuity
January 10, 2025 6:37 AM ESTCanaccord Genuity analyst William J. Plovanic raised the price target on Globus Medical (NYSE: GMED) to $101.00 (from $92.00) while maintaining a Buy rating.
The analyst comments "Model Update: We are updating our model post GMED's Q4/24 preannouncement last evening. As a reminder, last night GMED... More
